Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 7, 2020; 26(13): 1501-1512
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1501
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1501
Figure 2 Kaplan-Meier survival curves and risk tables for overall survival and recurrence-free survival in the validation cohort.
A: Gamma-glutamyltransferase to lymphocyte ratio > 33.7 was correlated with shorter overall survival; B: Recurrence-free survival in intrahepatic cholangiocarcinoma patients undergoing curative resection. OS: Overall survival; RFS: Recurrence-free survival; GLR: Gamma-glutamyltransferase to lymphocyte ratio; ICC: Intrahepatic cholangiocarcinoma.
- Citation: Wang JJ, Li H, Li JX, Xu L, Wu H, Zeng Y. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection. World J Gastroenterol 2020; 26(13): 1501-1512
- URL: https://www.wjgnet.com/1007-9327/full/v26/i13/1501.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i13.1501